Key points are not available for this paper at this time.
Abstract Purpose: Pathologists routinely analyze H Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts) ; 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (7Suppl): Abstract nr LB392.
Sukhadia et al. (Fri,) studied this question.